Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
About the prescription of exenatide and liraglutide, both compounds are contraindicated in MTC patients or multiple endocrine neoplasia syndrome 2 (MEN 2) patients due to the increased incidence of C-cell hyperplasia and tumors combined with elevated calcitonin levels in preclinical studies in rodents
78-LB: efficacy and safety of tirzepatide, a dual GIP/GLP-1 receptor agonist, compared with insulin degludec in patients with type 2 diabetes (SURPASS-3)
In vivo dual-modal imaging of glutathione with a rhodamine-Gd() based fluorescent/magnetic resonance probe
Apply early and be prepared for a screening process that typically takes 2 to 4 weeks
US$ 20.41
US$ 20.16
)
US$ 26.01
US$ 24.44
